Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Olysio

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olysio was produced by Janssen.

J&J starts to feel biosimilar competition bite

J&J starts to feel biosimilar competition bite toll on J&J's Olysio (simeprevir) and Incivek (telaprevir) products.

J&J signs $1bn deal with Achillion for hepatitis C therapies

J&J signs $1bn deal with Achillion for hepatitis C therapies J&J already has one new-generation oral HCV therapy on the market, its NS3/4A protease inhibitor Olysio (simeprevir), but could do with additional drugs in its portfolio in order ... In the US, sales of Olysio fell from $291m in the first-quarter of 2014

Harvoni sales rocket in first quarter

Harvoni sales rocket in first quarter But whilst sales are impressive, the pills are facing increasing competition from new hep C pills, including AbbVie's Viekira Pak (ombitasvir/paritaprevir/dasabuvir/ritonavir) and Bristol-Myers Squibb's Olysio

Sovaldi pushes Gilead to the top of US pharma list

Sovaldi pushes Gilead to the top of US pharma list The firm's drugs unit Janssen was bolstered by an array of new and diverse products, including its new hep C drug Olysio (simeprevir) and prostate cancer pill Zytiga (abiraterone acetate),

Top biotech firms saw sales jump in 2014

Top biotech firms saw sales jump in 2014 result of increased competition from Gilead's Sovaldi (sofosbuvir) and Janssen's Olysio (simeprevir).”.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....